Li, X.; Sun, L.; Stucky, A.; Tu, L.; Cai, J.; Chen, X.; Wu, Z.; Jiang, X.; Li, S.C.
Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”. Diagnostics 2022, 12, 617.
https://doi.org/10.3390/diagnostics12030617
AMA Style
Li X, Sun L, Stucky A, Tu L, Cai J, Chen X, Wu Z, Jiang X, Li SC.
Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”. Diagnostics. 2022; 12(3):617.
https://doi.org/10.3390/diagnostics12030617
Chicago/Turabian Style
Li, Xiaoqing, Lan Sun, Andres Stucky, Lingli Tu, Jin Cai, Xuelian Chen, Zhongjun Wu, Xuhong Jiang, and Shengwen Calvin Li.
2022. "Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”" Diagnostics 12, no. 3: 617.
https://doi.org/10.3390/diagnostics12030617
APA Style
Li, X., Sun, L., Stucky, A., Tu, L., Cai, J., Chen, X., Wu, Z., Jiang, X., & Li, S. C.
(2022). Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”. Diagnostics, 12(3), 617.
https://doi.org/10.3390/diagnostics12030617
